BMC Cancer Oncology

Baseline IFN-γ-based natural killer cell activity is associated with ex vivo expansion capacity of autologous NK cells in patients with breast cancer

Trang Thi Vu, Hai The Phung, Kien Trung Hoang, Tuan Ngoc Nguyen, Dung Dang Nguyen, Hai Anh Vu, Thuc Cong Luong, Dai Khac Do
Springer Nature · 2026-09-15 · DOI 10.1186/s12885-026-16978-0

Abstract

Abstract Background Natural killer (NK) cell-based immunotherapy is increasingly explored in cancer treatment; however, inter-individual variability in NK cell expansion remains a major challenge. Clinically applicable biomarkers reflecting NK cell functional fitness prior to expansion are limited. Methods Peripheral blood samples from 33 patients with breast cancer were analyzed using a standardized whole-blood interferon-gamma (IFN-γ) release assay to assess baseline NK cell activity. NK cells were subsequently expanded ex vivo from peripheral blood mononuclear cells under cytokine-based culture conditions. Associations were evaluated using Spearman’s rank correlation. Results Baseline NK cell activity showed a significant positive correlation with NK cell expansion capacity ( r = 0.46, p = 0.007). In contrast, age, leukocyte counts, peripheral NK cell frequency, and initial NK cell number were not significantly associated with expansion outcomes. Conclusions Baseline IFN-γ-based NK cell activity is associated with the ex vivo expansion capacity of autologous NK cells and may serve as a candidate biomarker for predicting ex vivo NK-cell expansion and warrants validation in larger studies for optimizing NK cell-based immunotherapy strategies in patients with breast cancer.

Read at publisher →